Table 7.
Comparison of patient characteristics between the BSC and LAT groups with C-P score 10 or 11, matched by propensity score.
| Background factors | BSC | LAT | p value |
|---|---|---|---|
| n=124 | n=124 | ||
| No. of Patients | No. of Patients | ||
| Age (years) | |||
| <60 | 35 | 35 | 1 |
| ≥60 | 89 | 89 | |
| Sex | |||
| Male | 80 | 75 | 0.5119 |
| Female | 44 | 49 | |
| Hepatitis B and C virological status | |||
| B−, C+ | 85 | 83 | 0.7645 |
| B+, C− | 14 | 13 | |
| B+, C+ | 1 | 3 | |
| B−, C− | 20 | 22 | |
| Maximum tumor size (cm) | |||
| ≤2 | 69 | 72 | 0.8605 |
| 2.1–3.0 | 47 | 43 | |
| 3.1–5.0 | 8 | 9 | |
| No. of tumors | |||
| 1 | 91 | 90 | 0.8863 |
| 2–3 | 33 | 34 | |
| TNM stage | |||
| I | 52 | 54 | 0.9636 |
| II | 56 | 54 | |
| III | 16 | 16 | |
| Bilirubin (mg/dL) | |||
| <2.0 | 31 | 27 | 0.8303 |
| 2.0–3.0 | 41 | 42 | |
| >3.0 | 52 | 55 | |
| Albumin (g/dL) | |||
| >3.5 | 0 | 1 | 0.5694 |
| 2.8–3.5 | 46 | 43 | |
| <2.8 | 78 | 80 | |
| PT (%) | |||
| >70 | 4 | 7 | 0.645 |
| 40–70 | 107 | 105 | |
| <40 | 13 | 12 | |
| Ascites | |||
| None | 44 | 40 | 0.86458 |
| Responsive | 53 | 56 | |
| Unresponsive | 27 | 28 | |
| Encephalopathy | |||
| None | 69 | 70 | 0.9361 |
| Mild | 36 | 37 | |
| Coma | 19 | 17 | |